Dementia News and Research

Latest Dementia News and Research

Neuroinflammation is the key upstream mechanism in Alzheimer’s disease progression

Neuroinflammation is the key driver of the spread of pathologically misfolded proteins in the brain and causes cognitive impairment in patients with Alzheimer's disease, researchers from the University of Pittsburgh School of Medicine reveal in a paper published today in Nature Medicine.

26 Aug 2021

Research shows increase in the registration of dementia as underlying cause of death

It is well known that dementia is associated with increased mortality. New scientific research shows how in recent years more deaths are being registered with dementia as the underlying cause of death.

26 Aug 2021

Non-invasive retinal imaging may be useful for detecting Alzheimer's disease risk

Amyloid plaques are protein deposits that collect between brain cells, hindering function and eventually leading to neuronal death.

23 Aug 2021

People with cognitively stimulating jobs have lower risk of dementia in old age, study finds

People with mentally stimulating jobs have a lower risk of dementia in old age than those with non-stimulating jobs, finds a study published by The BMJ today.

19 Aug 2021

Research aims to reduce the loss of speech and language in epilepsy patients

New research aims to shed light on reducing the loss of speech and language in epilepsy patients who require brain surgery to manage the condition.

18 Aug 2021

Research reveals link between widespread pain and heightened risk of dementia, stroke

Widespread pain is linked to a heightened risk of all types of dementia, including Alzheimer's disease, and stroke finds research.

17 Aug 2021

Brain diseases could have a greater societal impact than Covid-19, research finds

New research has found that brain diseases, such as Parkinson’s and Alzheimer’s, are surfacing earlier, proving more fatal, and could have a greater societal impact than Covid-19.

17 Aug 2021

Metabolism peaks much earlier and starts to decline later than you might think

Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism, the rate at which you burn calories, actually peaks much earlier and starts its inevitable decline later than you might think.

12 Aug 2021

Researcher receives $8.7 million to investigate the link between viral infections and memory disorders

More than half of the survivors of West Nile virus brain infections are left with memory disorders that make everyday tasks such as remembering the route from home to work challenging.

12 Aug 2021

Skin cells could provide better understanding of molecular mechanisms of frontotemporal dementia

A new study from the University of Eastern Finland suggests that skin fibroblasts from frontotemporal dementia patients may be useful in investigating underlying disease mechanisms as well as in biomarker and drug research.

12 Aug 2021

UQ-led telehealth project focuses on easing dementia’s burden on Indigenous Australians

Improving the impact of high dementia rates on Indigenous Australians and communities is the focus of a University of Queensland-led telehealth project with a global track record of success.

11 Aug 2021

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the more common white fat and providing protection from dementia.

10 Aug 2021

Study uncovers startling evidence from coroners' inquests into suicides of older people in the 1700s

Previous studies of suicide in the 1700s have focussed on societal attitudes rather than the experiences of people who took their own lives. These suicides have largely been described as 'medicalised' acts driven by lunacy.

10 Aug 2021

Study explores ‘brain fog’ following COVID-19

A recent survey conducted in the United Kingdom revealed that approximately one in every five experiences prolonged coronavirus disease 2019 (COVID-19) symptoms five weeks post-infection. Also, one in seven people reported persistent symptoms even after twelve weeks.

10 Aug 2021

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Ultra-sensitive Simoa® HD-X technology powers new findings that detect rapid reduction of plasma P-tau217 from donanemab, Lilly’s investigational antibody therapy for Alzheimer's disease at 12 weeks

From Quanterix 9 Aug 2021

Dementia News and Research

Latest Dementia News and Research

Neuroinflammation is the key upstream mechanism in Alzheimer’s disease progression

Research shows increase in the registration of dementia as underlying cause of death

Non-invasive retinal imaging may be useful for detecting Alzheimer's disease risk

People with cognitively stimulating jobs have lower risk of dementia in old age, study finds

Research aims to reduce the loss of speech and language in epilepsy patients

Research reveals link between widespread pain and heightened risk of dementia, stroke

Brain diseases could have a greater societal impact than Covid-19, research finds

Metabolism peaks much earlier and starts to decline later than you might think

Researcher receives $8.7 million to investigate the link between viral infections and memory disorders

Skin cells could provide better understanding of molecular mechanisms of frontotemporal dementia

UQ-led telehealth project focuses on easing dementia’s burden on Indigenous Australians

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Study uncovers startling evidence from coroners' inquests into suicides of older people in the 1700s

Study explores ‘brain fog’ following COVID-19

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

Study reveals structural differences and unique polymorphs in amyloid-β fibrils

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Study shows pharmacological rescue of mitochondrial defect related to Parkinson's disease

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dementia News and Research

Latest Dementia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in